Oncology Nursing Drug Handbook
ASO Keyword Dashboard
Tracking 58 keywords for Oncology Nursing Drug Handbook in Google Play
Oncology Nursing Drug Handbook tracks 58 keywords (no keywords rank yet; 58 need traction). Key metrics: opportunity 71.2, difficulty 40.9.
Written especially for nurses caring for patients with cancer.
Tracked keywords
58
0 ranked • 58 not ranking yet
Top 10 coverage
—
Best rank — • Latest leader —
Avg opportunity
71.2
Top keyword: patients
Avg difficulty
40.9
Lower scores indicate easier wins
Opportunity leaders
- 63.5
patients
Opportunity: 74.0 • Difficulty: 39.1 • Rank —
Competitors: 185
- 64.8
patient
Opportunity: 74.0 • Difficulty: 39.5 • Rank —
Competitors: 195
- 65.4
release
Opportunity: 74.0 • Difficulty: 49.3 • Rank —
Competitors: 761
- 61.4
chapters
Opportunity: 74.0 • Difficulty: 38.5 • Rank —
Competitors: 260
- 66.1
reviews
Opportunity: 74.0 • Difficulty: 51.3 • Rank —
Competitors: 638
Unranked opportunities
patients
Opportunity: 74.0 • Difficulty: 39.1 • Competitors: 185
patient
Opportunity: 74.0 • Difficulty: 39.5 • Competitors: 195
release
Opportunity: 74.0 • Difficulty: 49.3 • Competitors: 761
chapters
Opportunity: 74.0 • Difficulty: 38.5 • Competitors: 260
reviews
Opportunity: 74.0 • Difficulty: 51.3 • Competitors: 638
High competition keywords
new
Total apps: 370,270 • Major competitors: 21,630
Latest rank: — • Difficulty: 59.9
information
Total apps: 266,609 • Major competitors: 7,571
Latest rank: — • Difficulty: 55.3
offers
Total apps: 196,104 • Major competitors: 7,633
Latest rank: — • Difficulty: 55.0
provides
Total apps: 166,176 • Major competitors: 5,004
Latest rank: — • Difficulty: 55.1
provide
Total apps: 137,173 • Major competitors: 4,451
Latest rank: — • Difficulty: 52.3
All tracked keywords
Includes opportunity, difficulty, rankings and competitor benchmarks
| Major Competitors | |||||||
|---|---|---|---|---|---|---|---|
| new | 65 | 100 | 60 | 89 370,270 competing apps Median installs: 2,549 Avg rating: 2.0 | — | — | 21,630 major competitor apps |
| communication | 70 | 100 | 48 | 76 57,176 competing apps Median installs: 614 Avg rating: 1.6 | — | — | 1,193 major competitor apps |
| information | 65 | 100 | 55 | 86 266,609 competing apps Median installs: 1,036 Avg rating: 1.8 | — | — | 7,571 major competitor apps |
| valuable | 71 | 100 | 45 | 72 31,015 competing apps Median installs: 1,354 Avg rating: 1.8 | — | — | 1,051 major competitor apps |
| provide | 67 | 100 | 52 | 82 137,173 competing apps Median installs: 1,374 Avg rating: 1.8 | — | — | 4,451 major competitor apps |
| key | 68 | 100 | 53 | 81 118,372 competing apps Median installs: 1,169 Avg rating: 1.8 | — | — | 5,344 major competitor apps |
| understanding | 71 | 100 | 44 | 72 33,838 competing apps Median installs: 1,169 Avg rating: 1.6 | — | — | 687 major competitor apps |
| patients | 74 | 100 | 39 | 64 9,712 competing apps Median installs: 671 Avg rating: 1.8 | — | — | 185 major competitor apps |
| effective | 71 | 100 | 45 | 73 37,617 competing apps Median installs: 938 Avg rating: 1.8 | — | — | 1,137 major competitor apps |
| provides | 67 | 100 | 55 | 83 166,176 competing apps Median installs: 1,227 Avg rating: 1.8 | — | — | 5,004 major competitor apps |
| patient | 74 | 100 | 39 | 65 11,651 competing apps Median installs: 540 Avg rating: 1.7 | — | — | 195 major competitor apps |
| assist | 73 | 100 | 50 | 68 18,533 competing apps Median installs: 1,276 Avg rating: 1.9 | — | — | 713 major competitor apps |
| release | 74 | 100 | 49 | 65 12,776 competing apps Median installs: 3,292 Avg rating: 2.1 | — | — | 761 major competitor apps |
| includes | 69 | 100 | 50 | 77 66,636 competing apps Median installs: 2,094 Avg rating: 1.9 | — | — | 2,571 major competitor apps |
| nursing | 72 | 100 | 34 | 55 2,782 competing apps Median installs: 1,482 Avg rating: 1.8 | — | — | 42 major competitor apps |
| points | 70 | 100 | 48 | 76 56,487 competing apps Median installs: 1,828 Avg rating: 1.9 | — | — | 2,368 major competitor apps |
| especially | 72 | 100 | 45 | 70 23,391 competing apps Median installs: 2,742 Avg rating: 1.9 | — | — | 1,099 major competitor apps |
| side | 73 | 100 | 51 | 68 18,443 competing apps Median installs: 2,360 Avg rating: 2.0 | — | — | 969 major competitor apps |
| attention | 73 | 100 | 44 | 69 20,537 competing apps Median installs: 2,764 Avg rating: 2.0 | — | — | 1,134 major competitor apps |
| updated | 69 | 100 | 51 | 78 81,539 competing apps Median installs: 1,264 Avg rating: 1.8 | — | — | 2,926 major competitor apps |
| essential | 70 | 100 | 47 | 75 51,670 competing apps Median installs: 820 Avg rating: 1.7 | — | — | 1,610 major competitor apps |
| symptom | 71 | 100 | 39 | 49 1,266 competing apps Median installs: 1,547 Avg rating: 1.9 | — | — | 32 major competitor apps |
| effects | 72 | 100 | 50 | 71 29,029 competing apps Median installs: 8,993 Avg rating: 2.3 | — | — | 2,725 major competitor apps |
| drug | 73 | 100 | 35 | 56 3,432 competing apps Median installs: 1,459 Avg rating: 1.9 | — | — | 95 major competitor apps |
| chapters | 74 | 100 | 38 | 61 7,173 competing apps Median installs: 5,074 Avg rating: 1.9 | — | — | 260 major competitor apps |
App Description
Written especially for nurses caring for patients with cancer.
Completely revised and updated, the Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs.
New drugs include:
apalutamide (Erleada™)
calaspargase pegol-mknl (Asparlas™)
Daunorubicin and cytarabine liposome for injection (Vyxeos®)
glucarpidase (Voraxaze®)
alpelisib (Piqray®)
binimetinib (Mektovi®)
dacomitinib (Vizimpro®)
Duvelisib (Copiktra®)
encorafenib (Braftovi®)
erdafitinib (Balversa™)
lorlatinib (Lorbrena®)
anakinra (Kineret®)
baricitinib (Olumiant®)
sarilumab (Kevzara®)
aprepitant injectable emulsion (Cinvanti®)
granisetron hydrochloride extended-release injection (Sustol®)
letermovir (Prevymis™)
omadacycline (Nuzyra™)
meropenem/vaborbactam (Vabomere™)
Plazomicin (Zemdri™)
baloxavir marboxil (Xofluza™)
imipenem/cilastatin sodium/relebactam (Recarbrio™)
eravacycline (Xerava™)
delafloxacin (Baxdela™)